Zhejiang Taimei Medical Technology Proposes 2026 H Share Award Scheme and Initial Grants
I'm PortAI, I can summarize articles.
Zhejiang Taimei Medical Technology Co., Ltd. has proposed a 2026 H Share Award Scheme, pending shareholder approval. The board conditionally approved initial grants of 20,042,494 share awards to 63 participants, including directors and key employees, to retain talent and align interests with shareholders. The stock currently holds a Hold rating with a price target of HK$4.50. The company focuses on digital solutions in the healthcare sector and aims for long-term growth through equity-based compensation.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments